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Background:  Although echocardiographic measures of diastolic function are predictive of long-term outcome in several cardiovascular 
disease states, it is unresolved whether such parameters are reliable in hypertrophic cardiomyopathy (HCM). Heart failure (HF) is 
increasingly becoming the predominant cause of HCM mortality, making prediction of this clinical course of heightened concern.
methods:  Diastolic function parameters, assessed by mitral inflow, pulmonary venous flow, and Doppler tissue imaging (DTI), were 
measured in 404 consecutive adult HCM patients from 2003 to 2007. Patients reaching the primary endpoint prior to their initial 
echocardiogram (n=5) were excluded. Associations between diastolic parameters and long-term outcomes of death due to advanced 
HF, heart transplantation or progression to New York Heart Association [NYHA] class III-IV, as well as sudden death [SD]/implantable 
cardioverter-defibrillator [ICD] interventions were assessed.
results:  The composite HF end-point was reached in 43 patients with follow-up 6.4 ± 2.6 years. Diastolic parameters (assessed by 
DTI) associated with the HCM-HF outcomes included septal and lateral e’, and E/e’. None of the variables were associated with SD/ICD 
intervention.
conclusion:  In HCM, diastolic dysfunction assessed by DTI, is associated with adverse long-term HF outcome, but is not associated with 
SD. These echocardiographic markers provide a non-invasive strategy for anticipating progressive HF in HCM.
